Some Peculiarities of Growth and Functional Activity of Escherichia coli Strain from Probiotic Formula “ASAP“
Commenced in January 2007
Frequency: Monthly
Edition: International
Paper Count: 32807
Some Peculiarities of Growth and Functional Activity of Escherichia coli Strain from Probiotic Formula “ASAP“

Authors: Marine A. Balayan, Susanna S. Mirzabekyan, Marine Isajanyan, Zaven S. Pepoyan, Аrmen H. Trchounian, Аstghik Z. Pepoyan, Helena Bujdakova

Abstract:

It has been shown that pH 7,3 and 37 0C are the optimal condition for the growth of E. coli “ASAP". The cells grow well on Glucose, Lactose, D-Mannitol, D-Sorbitol, (+)-Xylose, L- (+)-Arabinose and Dulcitol. No growth has been observed on Sucrose, Inositol, Phenylalanine, and Tryptophan. The strain is sensitive to a range of antibiotics. The present study has demonstrated that E. coli “ASAP" inhibit the growth of S. enterica ATCC #700931 in vitro. The studies on conjugating activity has revealed no conjugant of E. coli “ASAP" with plasmid strains E. coli G35#59 and S. enterica ATCC #700931. On the other hand, the conjugants with low frequencies were obtained from E. coli “ASAP" with E. coli G35#61, and E. coli “ASAP" with randomly chosen isolate from healthy human gut microflora: E. coli E6. The results of present study have demonstrated improvements in gut microflora condition of patients with different diseases after the administration of “ASAP"

Keywords: E. coli, ASAP, Probiotic formula, gut microflora.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1075220

Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1718

References:


[1] M. Wilson, "Microbial inhabitants of humans. Their ecology and role in health and disease", In: Cambridge University Press. Cambridge. United Kingdom, 2005.
[2] A. Pepoyan and A. Trchounian, "Biophysics, molecular and cellular biology of probiotic activity by bacteria", In: Bacterial Membranes. Ultrastructure, Bioelectrochemistry, Biophysics and Bioenergetics. Ed. A. Trchounian. Kerala (India): Research Signpost, 2009.
[3] E. Cario, Curr Opin Gastroenterol, 2008, vol. 24, pp. 725-732.
[4] S.Doron, S.L. Gorbach, Expert Rev. Anti-infective, 2006, vol. 4, no. 2, pp. 261-275.
[5] M. Schultz, A.L. Lindström, Expert Rev. Gastroenterol. Hepatol, 2008, vol. 2, pp. 337-355.
[6] Marteau P., Seksik P., Jian R, Br. J. Nutr, 2002, vol. 88. (suppl 1): pp. 51-57.
[7] H.S. Gill, G. F. Postgrad, Med. J, 2004, vol. 80, pp. 516-526.
[8] I Wollowski, G Rechkemmer, BL Pool-Zobel, Am. J. Clin. Nutr, 2001, vol. 73, pp. 451-455.
[9] Y. Aso, H.Akazan, T. Kotake, T. Tsukamoto, K. Imai, S. Naito, Eur. Urology, 1995, vol. 27, pp. 104-109.
[10] D. Haller, S. Blum, C. Bode, W.P. Hammes, E.J. Schiffrin, Infection and Immunity, 2000, vol. 68, pp. 752-759.
[11] B. Corthesy, H.R. Gaskins, A. Mercenier, J. Nutr. 2007, vol. 137, pp. 781-790.
[12] K.Madsen, A.Cornish, P.Soper, C.McKaigney, H.Jijon, C.Yachimec, J.Doyle, L. Jewell, C.De Simone, Gastroenterology, 2001, vol. 121, pp. 580-591.
[13] G.W. Elmer, Am. J. Health Syst. Pharm, 2001, vol. 58, pp. 1101-1109.
[14] D.Damaskos, G.Kolios, Br. J. Clin. Pharmacol, 2008, vol. 65, no. 4, pp. 453-67.
[15] ðÉ.ðù. ðƒðÁð┐ð¥ÐÅð¢, "ð¿Ðéð░ð╝ð╝ ð▒ð░ð║ÐéðÁÐÇð©ð╣ Escherichia coli "ðÉðíðÉðƒ", ð©Ðüð┐ð¥ð╗ÐîðÀÐâðÁð╝Ðïð╣ ð┤ð╗ÐÅ ð┐ð¥ð╗ÐâÐçðÁð¢ð©ÐÅ ð┐ÐÇð¥ð▒ð©ð¥Ðéð©ÐçðÁÐüð║ð¥ð│ð¥ ð┐ÐÇðÁð┐ð░ÐÇð░Ðéð░, ð© ð┐ÐÇð¥ð▒ð©ð¥Ðéð©ÐçðÁÐüð║ð©ð╣ ð┐ÐÇðÁð┐ð░ÐÇð░Ðé ð¢ð░ ð¥Ðüð¢ð¥ð▓ðÁ ÐìÐéð¥ð│ð¥ ÐêÐéð░ð╝ð╝ð░": ð╗ð©ÐåðÁð¢ðÀð©ÐÅ #1834-P20050220, In: ðÉð│ðÁð¢ÐéÐüÐéð▓ð¥ ð©ð¢ÐéðÁð╗ð╗ðÁð║ÐéÐâð░ð╗Ðîð¢ð¥ð╣ Ðüð¥ð▒ÐüÐéð▓ðÁð¢ð¢ð¥ÐüÐéð© ðáðÁÐüð┐Ðâð▒ð╗ð©ð║ð© ðÉÐÇð╝ðÁð¢ð©ÐÅ. ðòÐÇðÁð▓ð░ð¢, 2006.
[16] M.L. Marco, S. Pavan, M. Kleerebezem, Curr. Opin. Biotechnol. 2006, vol. 17, no. 2, pp. 204-210.
[17] S.I. Patzer, M.R. Baquero, D. Bravo, F. Moreno, K. Hantke, Microbiology, 2003, vol. 149, pp. 2557-2570.
[18] M. Valdebenito, A.L. Crumbliss, G. Winkelmann, K. Hantke, Int. J. Med. Microbiol, 2006, vol. 296, pp. 513-520.
[19] J. Boudeau, A.L. Glasser, S. Julien, J.F. Colombel, A. Darfeuille- Michaud, Aliment Pharmacol. Ther, 2003, vol. 18, pp. 45-56.
[20] A. fer Altenhoe, S. Oswald, U. Sonnenborn, C. Enders, J. Schulze, J. Hacker, T. A. Oelschlaeger, FEMS Immunol. Med. Microbiol, 2004, vol. 40, pp. 223-229.
[21] J. Wehkamp, J. Harder, K. Wehkamp, Infection and Immunity. 2004, vol. 72, pp. 5750-5758.
[22] S.N. Ukena, A.M. Westendorf, W. Hansen, M. Rohde, R. Geffers, S. Coldewey, S. Suerbaum, J. Buer, F. Gunzer, BMC Med. Genet, 2005, vol. 6, p. 43.
[23] A.A. Zyrek, C. Cichon, S. Helms, C. Enders, U. Sonnenborn, M.A. Schmidt, Cell Microbiol, 2007, vol. 9, pp. 804-816.
[24] A. Von Wright, Curr. Pharm. Des, 2005, vol. 11, pp. 17-23.
[25] D.C. Donohue, Asian Pac. J. Clin. Nutr, 2006, vol. 15, pp. 563-569.
[26] ðÜ. ðíÐéðÁð┐ð░ð¢ÐÅð¢, ð£. ðæð░ð╗ð░ÐÅð¢, ðÉ. ðÆð░Ðüð©ð╗ÐÅð¢, ðÉ. ðƒðÁð┐ð¥ÐÅð¢, ðÉ. ðóÐÇÐçÐâð¢ÐÅð¢, ðæð©ð¥ð╗. ð£ðÁð╝ð▒ÐÇð░ð¢Ðï, 2007, vol. 24, pp. 389-394.
[27] A. Shahinyan, J. Garibyan, A. Pepoyan, O. Karapetyan, New El. J. Nat. Sci, 2003, vol. 1, pp. 53-58.
[28] A. Trchounian, E. Ohanjanyan, K. Bagramyan, E. Zakharyan, V. Vardanian, A. Vassilian, M. Davtian, Biosci. Rep, 1998, vol. 18, pp. 143-154.
[29] N. Mirzoyan, A. Pepoyan, A. Trchounian, FEMS Microbiol. Lett, 2006, vol. 254, pp. 81-86.
[30] E.S. Lennox, Virology, 1955, vol. 1, p. 190.
[31] P.R. Murray, E.J. Baron, M.A. Pfaller, P.C. Tenover, R.H. Yolken, (eds): Manual of Clinical Microbiology. 6th ed., ASM Press, Washington, DC, 1995.
[32] N.C. Birnboim, J.A. Doli, Nucl. Acid Res, 1979, vol. 7, pp. 1513-1518.
[33] R.M. Reyed, The Internet J. Biol. Anthropol, 2007, vol. 3, No 2.
[34] N.M. Clark, J. Patterson, J.P. Lynch, Curr. Opin. Crit. Care, 2003, vol. 9, pp. 413-423.
[35] T. Barbosa, S. B. Levy, Drug Resistance Updates, 2000, vol. 3, pp. 303- 311.
[36] A.A. Salyers, A. Gupta, Y. Wang, Trends Microbiol, 2004, vol. 12, no. 9, pp. 412-416.
[37] D.P. Blake, K. Hillman, D.R. Fenlon, J.C. Low, J. Appl. Microbiol, 2003, vol. 95, no 3, pp. 428-436.
[38] H. Kruse, H. Sorum, Appl. Environ. Microbiol, 1994, vol. 60, no. 11, pp. 4015-4021.
[39] F. Doucet-Populaire, P. Trieu-Cuot, A. Andremont, P. Courvalin, Antimicrob. Agents Chemother, 1992, vol. 36(2), pp. 502-504.
[40] P. Gionchetti, F. Rizzello, K.M. Lammers, C. Morselli, L Sollazzi., S. Davies, R. Tambasco, C. Calabrese, M. Campieri, World J. Gastroenterol, 2006, vol. 12, no. 21, pp. 3306-3313.
[41] G.E. Bergonzelli, S. Blum, H. Brussow, I. Corthe'sy-Theulaz, Digestion, 2005, vol. 72, no. 1, pp. 57-68.
[42] E.S. Huebner, C.M. Surawicz, Gastroenterol. Clin. North. Am, 2006, vol. 35, pp. 355-365.
[43] H.S. Gill, Best Pract. Res. Clin. Gastroenterol, 2003, vol. 17, pp. 755- 773.
[44] R. Reissbrodt, W.P. Hammes, F. dal Bello, R. Prager, A. Fruth, K. Hantke, A. Rakin, M. Starcic-Erjavec, P.H. Williams, FEMS Microbiol Lett., 2009, vol. 290, no. 1, pp. 62-69.
[45] M. Boirivant, W. Strober, Curr. Opin. Gastroenterol, 2007, vol. 23, no. 6, pp. 679-692.
[46] ðØ.ð£. ðôÐÇð░ÐçðÁð▓ð░, ðÆ.ð£. ðæð¥ð¢ð┤ð░ÐÇðÁð¢ð║ð¥, ðÿð¢ÐäðÁð║Ðå. ðæð¥ð╗ðÁðÀð¢ð©, 2004, vol. 2, no. 2, pp. 53-58.
[47] ðÆ.ð£. ðæð¥ð¢ð┤ð░ÐÇðÁð¢ð║ð¥, ðÉ.ðÉ. ðÆð¥ÐÇð¥ð▒ÐîðÁð▓, ðûÐâÐÇð¢. ð╝ð©ð║ÐÇð¥ð▒ð©ð¥ð╗., Ðìð┐ð©ð┤ðÁð╝ð©ð¥ð╗. ð©ð╝ð╝Ðâð¢ð¥ð▒ð©ð¥ð╗. 2004, pp. 84-92.